
A panel of experts including Jacqueline Capeau, MD, PhD; Peter Reiss, MD, PhD; and William G. Powderly, MD, reviews current clinical trial data regarding metabolic complications in HIV-infected patients, including epidemiology, switch strategies, lipid-lowering treatment, insulin resistance, and lipodystrophy.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Explain the epidemiology of cardiovascular risk factors in HIV-infected patients
- Discuss the associations between specific antiretroviral agents and metabolic complications and the implications of these data for treatment strategies
- Describe approaches to the management of hyperlipidemia, insulin resistance, and body fat perturbations in HIV-infected patients